Last Updated: September 24, 2026

TRIMIPRAMINE MALEATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Trimipramine Maleate, and when can generic versions of Trimipramine Maleate launch?

Trimipramine Maleate is a drug marketed by Breckenridge, Elite Labs Inc, and Usl Pharma. and is included in five NDAs.

The generic ingredient in TRIMIPRAMINE MALEATE is trimipramine maleate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the trimipramine maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Trimipramine Maleate

A generic version of TRIMIPRAMINE MALEATE was approved as trimipramine maleate by ELITE LABS INC on August 2nd, 2006.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for TRIMIPRAMINE MALEATE?
  • What are the global sales for TRIMIPRAMINE MALEATE?
  • What is Average Wholesale Price for TRIMIPRAMINE MALEATE?
Pharmacology for TRIMIPRAMINE MALEATE
Medical Subject Heading (MeSH) Categories for TRIMIPRAMINE MALEATE

US Patents and Regulatory Information for TRIMIPRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Breckenridge TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 208127-001 Apr 15, 2016 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Usl Pharma TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 071283-001 Dec 8, 1987 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Elite Labs Inc TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 077361-001 Aug 2, 2006 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Usl Pharma TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 071284-001 Dec 8, 1987 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.